In drug development and production, good clinical practice is an international quality standard, which governments can then transpose into regulations for clinical trials involving human subjects. From Wikipedia
Investors allege lack of oversight and significant non-compliance in BioVie's Phase 3 clinical trial, leading to a dramatic drop in stock prices.
